In vitro and in vivo characterization of porous poly-L-lactic acid coatings for subcutaneously implanted glucose sensors.

The purpose of this study was to test the hypothesis that porous poly-L-lactic acid (PLLA) sensor coatings reduce fibrosis and promote blood microvessel formation in tissue adjacent to the sensor surface. Porous PLLA coatings were produced using ammonium bicarbonate as the gas foaming/salt leaching agent, and deployed on functional and nonfunctional sensors. The porous coatings minimally affected sensor accuracy and response rate in vitro. Three-week subcutaneous rat studies of nonfunctional glucose sensors showed the anticipated effect of porous coatings enhancing vascularity and decreasing collagen deposition. In contrast, percutaneous functional sensors with and without porous coatings showed no significant difference in terms of histology or sensor response. In spite of the observation that texturing increases the vascularity of the tissue that surrounds implanted sensors, other factors such as the additional mechanical stresses imposed by percutaneous tethering may override the beneficial effects of the porous coatings.

[1]  W M Reichert,et al.  Engineering the tissue which encapsulates subcutaneous implants. I. Diffusion properties. , 1997, Journal of biomedical materials research.

[2]  W Kenneth Ward,et al.  The effect of local subcutaneous delivery of vascular endothelial growth factor on the function of a chronically implanted amperometric glucose sensor. , 2004, Diabetes technology & therapeutics.

[3]  E. Maynard,et al.  A technique to prevent dural adhesions to chronically implanted microelectrode arrays , 2000, Journal of Neuroscience Methods.

[4]  Giridharan Gokulrangan,et al.  Mediation of in vivo glucose sensor inflammatory response via nitric oxide release. , 2005, Journal of biomedical materials research. Part A.

[5]  K. Friedl.  Corticosteroid modulation of tissue responses to implanted sensors. , 2004, Diabetes technology & therapeutics.

[6]  S. Berman,et al.  The effects of porosity on endothelialization of ePTFE implanted in subcutaneous and adipose tissue. , 1997, Journal of biomedical materials research.

[7]  N Wisniewski,et al.  Characterization of implantable biosensor membrane biofouling , 2000, Fresenius' journal of analytical chemistry.

[8]  Buddy D. Ratner,et al.  Biomaterials with tightly controlled pore size that promote vascular in-growth , 2004 .

[9]  Francis Moussy,et al.  Strategies for testing long-term transcutaneous amperometric glucose sensors. , 2005, Diabetes technology & therapeutics.

[10]  Jae Ho Shin,et al.  Improving the biocompatibility of in vivo sensors via nitric oxide release. , 2006, The Analyst.

[11]  M. Textor,et al.  Effects of surface topography on the connective tissue attachment to subcutaneous implants. , 2006, The International journal of oral & maxillofacial implants.

[12]  W M Reichert,et al.  In vitro characterization of vascular endothelial growth factor and dexamethasone releasing hydrogels for implantable probe coatings. , 2005, Biomaterials.

[13]  Abhay Pandit,et al.  Fabrication methods of porous metals for use in orthopaedic applications. , 2006, Biomaterials.

[14]  T. Park,et al.  A novel fabrication method of macroporous biodegradable polymer scaffolds using gas foaming salt as a porogen additive. , 2000, Journal of biomedical materials research.

[15]  Wisniewski,et al.  Methods for reducing biosensor membrane biofouling. , 2000, Colloids and surfaces. B, Biointerfaces.

[16]  J. Jansen,et al.  Effect of microtextured surfaces on the performance of percutaneous devices. , 2005, Journal of biomedical materials research. Part A.

[17]  R. C. Johnson,et al.  Neovascularization of synthetic membranes directed by membrane microarchitecture. , 1995, Journal of biomedical materials research.

[18]  M. Shults,et al.  A subcutaneous glucose sensor with improved longevity, dynamic range, and stability of calibration. , 2000, Diabetes care.

[19]  M. Schoenfisch,et al.  Inhibition of implant-associated infections via nitric oxide release. , 2005, Biomaterials.

[20]  K J Gooch,et al.  Biomaterial-microvasculature interactions. , 2000, Biomaterials.

[21]  T. Bauer,et al.  The pathology of total joint arthroplasty , 1999, Skeletal Radiology.

[22]  W M Reichert,et al.  Engineering the tissue which encapsulates subcutaneous implants. II. Plasma-tissue exchange properties. , 1998, Journal of biomedical materials research.

[23]  B. Griffith,et al.  Fine trabecularized carbon: ideal material and texture for percutaneous device system of permanent left ventricular assist device. , 1998, Artificial organs.

[24]  W Kenneth Ward,et al.  The effect of microgeometry, implant thickness and polyurethane chemistry on the foreign body response to subcutaneous implants. , 2002, Biomaterials.

[25]  S. Woodward.  How Fibroblasts and Giant Cells Encapsulate Implants: Considerations in Design of Glucose Sensors , 1982, Diabetes Care.

[26]  Heidi E Koschwanez,et al.  In vitro, in vivo and post explantation testing of glucose-detecting biosensors: current methods and recommendations. , 2007, Biomaterials.

[27]  J. Muthuswamy,et al.  Brain micromotion around implants in the rodent somatosensory cortex , 2006, Journal of neural engineering.

[28]  Francis Moussy,et al.  A long-term flexible minimally-invasive implantable glucose biosensor based on an epoxy-enhanced polyurethane membrane. , 2006, Biosensors & bioelectronics.

[29]  Peter G Jacobs,et al.  Feasibility of continuous long-term glucose monitoring from a subcutaneous glucose sensor in humans. , 2004, Diabetes technology & therapeutics.

[30]  P. Ma,et al.  Poly(alpha-hydroxyl acids)/hydroxyapatite porous composites for bone-tissue engineering. I. Preparation and morphology. , 1999, Journal of biomedical materials research.

[31]  Miqin Zhang,et al.  Preparation of porous hydroxyapatite scaffolds by combination of the gel-casting and polymer sponge methods. , 2003, Biomaterials.

[32]  W. Kofke,et al.  Comparison of the effects of volatile anesthetics in varying concentrations on brain energy metabolism with brain ischemia in rats , 1992, Neurochemical Research.

[33]  Buddy D Ratner,et al.  A model for studying epithelial attachment and morphology at the interface between skin and percutaneous devices. , 2005, Journal of biomedical materials research. Part A.

[34]  J. Halter,et al.  Pentobarbital anesthesia suppresses basal and 2-deoxy-D-glucose-stimulated plasma catecholamines. , 1984, The American journal of physiology.

[35]  T. Bauer,et al.  The pathology of total joint arthroplasty. I. Mechanisms of implant fixation. , 1999, Skeletal radiology.

[36]  G. S. Wilson,et al.  Biosensors for real-time in vivo measurements. , 2005, Biosensors & bioelectronics.

[37]  W M Reichert,et al.  Engineering the tissue which encapsulates subcutaneous implants. III. Effective tissue response times. , 1998, Journal of biomedical materials research.